gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 08 Nov 2015.

Epilepsy, progressive myoclonus type 2A, Lafora disease

EPM2A, malin, EPM2B, Laforin, NHLRC1
This gene encodes a dual-specificity phosphatase that associates with polyribosomes. The encoded protein may be involved in the regulation of glycogen metabolism. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008] (from NCBI)
Top mentioned proteins: Ubiquitin, AGE, CAN, HAD, ACID
Papers on EPM2A
Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex.
Sanz et al., Valencia, Spain. In Int J Biochem Cell Biol, 03 Dec 2015
UNASSIGNED: Lafora disease (LD, OMIM254780, ORPHA501) is a rare neurodegenerative form of epilepsy related to mutations in two proteins: laforin, a dual specificity phosphatase, and malin, an E3-ubiquitin ligase.
Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy.
Pallardó et al., Valencia, Spain. In Free Radic Biol Med, 30 Nov 2015
Lafora disease (LD; OMIM 254780, ORPHA501) is a devastating neurodegenerative disorder characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies and caused, in most cases, by mutations in either the EPM2A or the EPM2B gene, encoding respectively laforin, a phosphatase with dual specificity that is involved in the dephosphorylation of glycogen, and malin, an E3-ubiquitin ligase involved in the polyubiquitination of proteins related to glycogen metabolism.
Muscle Glycogen Remodeling and Glycogen Phosphate Metabolism following Exhaustive Exercise of Wild Type and Laforin Knockout Mice.
Roach et al., Indianapolis, United States. In J Biol Chem, 11 Oct 2015
Loss-of-function mutations in the laforin gene cause the fatal neurodegenerative disorder, Lafora disease, characterized by increased glycogen phosphorylation and the formation of abnormal deposits of glycogen-like material called Lafora bodies.
Brain glycogen in health and disease.
Guinovart et al., Barcelona, Spain. In Mol Aspects Med, 04 Oct 2015
Loss-of-function mutations in laforin and malin cause Lafora disease.
Polyglucosan storage myopathies.
Oldfors et al., Göteborg, Sweden. In Mol Aspects Med, Sep 2015
Mutations in eight human genes are known to be associated with polyglucosan storage involving muscle, namely GYG1, GBE1, RBCK1 (HOIL-1), PFKM, EPM2A, EPM2B (NHLRC1), PRDM8, and PRKAG2.
Non-invasive gene targeting to the fetal brain after intravenous administration and transplacental transfer of plasmid DNA using PEGylated immunoliposomes.
Pardridge et al., Los Angeles, United States. In J Drug Target, Aug 2015
In addition to studies of normal wild-type mice, we similarly injected pregnant Lafora Knockout (EPM2a null-mutant) and demonstrated luciferase activity days later in the maternal and newborn pup brains of both types.
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
Lehesjoki et al., Helsinki, Finland. In Nat Genet, Jan 2015
Ten cases had pathogenic mutations in known PME-associated genes (NEU1, NHLRC1, AFG3L2, EPM2A, CLN6 and SERPINI1).
The laforin/malin E3-ubiquitin ligase complex ubiquitinates pyruvate kinase M1/M2.
Sanz et al., Valencia, Spain. In Bmc Biochem, Dec 2014
BACKGROUND: Lafora disease (LD, OMIM 254780) is a fatal neurodegenerative disorder produced mainly by mutations in two genes: EPM2A, encoding the dual specificity phosphatase laforin, and EPM2B, encoding the E3-ubiquitin ligase malin.
Increased oxidative stress and impaired antioxidant response in Lafora disease.
Sanz et al., Valencia, Spain. In Free Radic Biol Med, Oct 2014
Lafora Disease (LD, OMIM 254780, ORPHA501) is a fatal neurodegenerative disorder characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies and caused, in the vast majority of cases, by mutations in either EPM2A or EPM2B genes, encoding respectively laforin and malin.
Unclassified cardiomyopathies in neuromuscular disorders.
Stöllberger et al., Vienna, Austria. In Wien Med Wochenschr, 2013
Takotsubo syndrome has been described in association with myasthenia gravis, amyotrophic lateral sclerosis, Guillain-Barre syndrome, rhabdomyolysis, mitochondrial disorder, hypokalemia-related myopathy, syndrome malin, hereditary sensorimotor neuropathy, Beals syndrome, polymyalgia rheumatica, and unclassified myopathy.
Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease.
Minassian et al., Potsdam, Germany. In Cell Metab, 2013
Laforin or malin deficiency causes Lafora disease, characterized by altered glycogen metabolism and teenage-onset neurodegeneration with intractable and invariably fatal epilepsy.
Progressive myoclonus epilepsy.
Minassian et al., Toronto, Canada. In Handb Clin Neurol, 2012
It is caused by defects of two genes of yet unknown function, one encoding a glycogen phosphatase (laforin) and the other an ubiquitin E3 ligase (malin).
Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
Minassian et al., Toronto, Canada. In J Biol Chem, 2012
malin functions to regulate laforin and that malin deficiency at least in part causes LB and LD through increased laforin binding to glycogen.
Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.
Delgado-Escueta et al., Los Angeles, United States. In Exp Neurol, 2012
A detailed microscopic analysis of the neuropil of a Laforin-deficient (epm2a-/-) mouse model shows neurofibrillary degeneration and senile-like plaques prominent in the hippocampus and ventral pons.
Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells.
Liu et al., Ann Arbor, United States. In Febs J, 2012
Results show that a functional laforin-malin complex plays a critical role in disrupting Lafora bodies and relieving endoplasmic reticulum stres.
Laforin and malin deletions in mice produce similar neurologic impairments.
Sánchez et al., Madrid, Spain. In J Neuropathol Exp Neurol, 2012
Motor coordination, activity impairment, and memory deficits progressively increase with age in Epm2a deficient mice.
Malin regulates Wnt signaling pathway through degradation of dishevelled2.
Jana et al., Gurgaon, India. In J Biol Chem, 2012
Our results indicate that malin regulates Wnt signaling pathway through the degradation of dishevelled2 and suggest possible deregulation of Wnt signaling in Lafora disease.
Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling.
Zheng et al., Columbus, United States. In Cancer Cell, 2006
Inactivation of Epm2a resulted in increased Wnt signaling and tumorigenesis
Expanded repeat in canine epilepsy.
Minassian et al., Toronto, Canada. In Science, 2005
A canid-specific unstable dodecamer repeat in the Epm2b (Nhlrc1) gene recurrently expands, causing a fatal epilepsy and contributing to the high incidence of canine epilepsy.
Mutations in NHLRC1 cause progressive myoclonus epilepsy.
Scherer et al., Toronto, Canada. In Nat Genet, 2003
Laforin and malin colocalize to the ER, suggesting they operate in a related pathway protecting against polyglucosan accumulation and epilepsy
share on facebooktweetadd +1mail to friends